Zacks Research Comments on Integer’s Q2 Earnings (NYSE:ITGR)

Integer Holdings Co. (NYSE:ITGR) – Stock analysts at Zacks Research boosted their Q2 2025 earnings per share (EPS) estimates for Integer in a research report issued on Thursday, March 13th. Zacks Research analyst D. Dey now anticipates that the medical equipment provider will post earnings per share of $1.44 for the quarter, up from their prior estimate of $1.43. The consensus estimate for Integer’s current full-year earnings is $6.01 per share. Zacks Research also issued estimates for Integer’s Q3 2025 earnings at $1.57 EPS, FY2025 earnings at $5.98 EPS, Q1 2026 earnings at $1.59 EPS, Q2 2026 earnings at $1.54 EPS, FY2026 earnings at $6.58 EPS and FY2027 earnings at $7.15 EPS.

Several other equities analysts have also weighed in on ITGR. Wells Fargo & Company reaffirmed an “overweight” rating and issued a $160.00 price objective on shares of Integer in a research note on Tuesday, December 3rd. Benchmark lifted their price objective on Integer from $140.00 to $150.00 and gave the company a “buy” rating in a research note on Friday, February 21st. KeyCorp lifted their price objective on Integer from $144.00 to $154.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. Oppenheimer lowered Integer from an “outperform” rating to a “market perform” rating in a research note on Friday, February 21st. Finally, Truist Financial boosted their price target on Integer from $147.00 to $163.00 and gave the stock a “buy” rating in a research report on Wednesday, December 11th. Two investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to MarketBeat.com, Integer currently has an average rating of “Moderate Buy” and an average price target of $149.00.

Integer Stock Up 1.2 %

ITGR opened at $119.25 on Monday. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.95 and a quick ratio of 2.09. The stock has a market capitalization of $4.01 billion, a price-to-earnings ratio of 35.49, a price-to-earnings-growth ratio of 1.72 and a beta of 1.24. The business has a 50-day moving average of $133.82 and a two-hundred day moving average of $132.69. Integer has a 12 month low of $107.11 and a 12 month high of $146.36.

Integer (NYSE:ITGR) last posted its quarterly earnings data on Thursday, February 20th. The medical equipment provider reported $1.43 EPS for the quarter, missing analysts’ consensus estimates of $1.46 by ($0.03). The company had revenue of $449.50 million for the quarter, compared to analysts’ expectations of $446.28 million. Integer had a return on equity of 11.65% and a net margin of 6.92%.

Institutional Investors Weigh In On Integer

Institutional investors and hedge funds have recently made changes to their positions in the company. Crossmark Global Holdings Inc. increased its position in Integer by 14.7% in the third quarter. Crossmark Global Holdings Inc. now owns 2,899 shares of the medical equipment provider’s stock worth $377,000 after buying an additional 372 shares during the period. State of New Jersey Common Pension Fund D increased its position in Integer by 1.8% in the third quarter. State of New Jersey Common Pension Fund D now owns 15,582 shares of the medical equipment provider’s stock worth $2,026,000 after buying an additional 268 shares during the period. Huntington National Bank increased its position in Integer by 8,933.3% in the third quarter. Huntington National Bank now owns 271 shares of the medical equipment provider’s stock worth $35,000 after buying an additional 268 shares during the period. Natixis Advisors LLC increased its position in Integer by 3.7% in the third quarter. Natixis Advisors LLC now owns 45,048 shares of the medical equipment provider’s stock worth $5,856,000 after buying an additional 1,609 shares during the period. Finally, Prudent Man Advisors LLC acquired a new stake in Integer in the third quarter worth $209,000. 99.29% of the stock is owned by institutional investors and hedge funds.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.